INZOLEN-Infusio E Infusionslösung
Recall
|
Medicines
|
23/12/2022
The marketing authorisation holder informed its customers on December 23, 2022 that decreased dexpanthenol concentrations were detected during the ongoing stability programme. For this reason the batches mentioned below are being recalled. The medicinal product is authorised in Germany and placed on the market in Austria under the Austrian Act on the Import of Medicinal Products.
| Name of the medicinal product | INZOLEN-Infusio E Infusionslösung |
|---|---|
| Marketing authorisation number(s) | Deutschland: 6072844.00.00 |
| CIP code | Deutschland: 842726 4 |
| Marketing authorisation holder | Dr. Franz Köhler Chemie GmbH |
| Batch number(s) | 2105511, 2105512, 2105611 |
| Expiry date | 01/31/2023 |
| Classification of the recall | 2 |
| Depth of recall | Pharmacies |
| BASG reference number | INS-640.001-4131 |
Further inquiry note
Page last modified:
23/12/2022